Navigation Links
FDA Advisers Consider New Lupus Drug
Date:11/16/2010

By Steven Reinberg
HealthDay Reporter

TUESDAY, Nov. 16 (HealthDay News) -- U.S. Food and Drug Administration advisers were weighing Tuesday whether to recommend the first new drug in more than 50 years to treat the autoimmune disease lupus.

The drug, belimumab (Benlysta), is a so-called monoclonal antibody drug developed to treat patients who suffer from systemic lupus erythematosus.

In research papers submitted to the advisory committee, the full FDA expressed some concerns about the efficacy and safety of the drug.

"I really do think the drug is efficacious," said Sandra C. Raymond, president & CEO of the Lupus Foundation of America, who was attending the advisory panel meeting. "What I'm hearing in terms of efficacy is pretty strong."

The FDA said it wants the advisory panel to look at both the efficacy data, which according to the agency is modest, and the safety data, which the agency believes raises some serious issues. Specifically, the drug has been linked to depression and suicide.

Raymond noted that many patients with lupus suffer from depression. And many patients in clinical trials testing the drug were also taking antidepressants, she added.

The advisory committee is scheduled to vote on whether the drug's risks are mitigated by the benefits it has to offer to patients who are already receiving standard care.

The agency said it is basing its concerns on the results of two phase 3 trials that compared Benlysta with a placebo.

"The risks associated with belimumab include infection, malignancy, suicidality, and overall number of deaths with a numerical imbalance that favored placebo treatment over belimumab treatment," according to the FDA.

Safety is important, Raymond said, but the drugs used to treat lupus now carry some significant side effects, too. "The safety of some of our medications is not good," she said. "So what are we comparing it to?"

The
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

0

GOOD

Page: 1 2

Related medicine news :

1. FDA Advisers Back Anemia Drugs for Kidney Patients
2. FDA Advisers Consider Approval of Genetically Modified Salmon
3. FDA Advisers Weigh Approval of Genetically Modified Salmon
4. FDA Advisers Divided on Whether to Ban Diet Drug Meridia
5. FDA Advisers Say Avastin Shouldnt Be Used for Breast Cancer
6. FDA to Broaden Disclosure on Advisers Conflicts of Interest
7. FDA Advisers Urge Stricter Regulation of Tanning Beds
8. Considerable proportion of patients with advanced cancer continue to undergo common cancer screening
9. ConnectedIn Divorce Resource Offers Online Expert Website for People Considering or Going Through Divorce
10. BMEGateway's 20th Anniversary Insurance Symposium considered a “Tremendous” Success
11. Newly Relaunched Autoinsurance.net Offers Consumers Smart Tips To Consider When Purchasing Car Insurance
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Advisers Consider New Lupus Drug
(Date:5/20/2013)... May 20, 2013 Idol lash has designed ... darker and fuller eyelashes in a matter of few weeks. ... online purchase with an extra pack offer to help more ... access this offer on the Idol lash official website. , ... increase the eyelash density up to 82% in just a ...
(Date:5/20/2013)... 20, 2013 The US Drug ... of a transvaginal mesh failure, we are now calling ... we have ever seen for women, and the damages ... a potentially huge number of US women. According to ... underwent procedures in which mesh was implanted vaginally to ...
(Date:5/20/2013)... Atlanta, GA (PRWEB) May 20, 2013 ... Vision Institute published a testimonial about how one of ... for a LASIK consultation after being diagnosed with giant ... a foreign object in the eye, and for one ... lenses that caused this allergy,” says the Medical Director ...
(Date:5/20/2013)... 2013 The Mesothelioma Victims Center ... Navy Veterans who are diagnosed with mesothelioma get shortchanged ... they, or their family members turned to a local ... of the most skilled, and experienced mesothelioma lawyers in ... mesothelioma in the US never even bother to explore ...
(Date:5/20/2013)... 20, 2013 Milpitas, Los Angeles, ... leader in enterprise-class information archiving, eDiscovery and migration ... 7.0, the latest release in the MessageSolution product ... the legal discovery lifecycle. MessageSolution will exhibit at ... CA. , As the first stop of the ...
Breaking Medicine News(10 mins):Health News:Idol Lash Eyelash Growth Enhancer Now Offered Extra Pack for Limited Time Only at HealthCareSupplementz.com 2Health News:US Drug Watchdog Now Urges Transvaginal Mesh Failure Victims With Erosion To Call Them For The Names And Contacts Of The Best Women Attorneys 2Health News:Atlanta LASIK Practice Publishes a Patient’s Testimonial About Allergy to Contact Lenses 2Health News:Mesothelioma Victims Center Urges US Navy Veterans Diagnosed With Mesothelioma To Call Them For The Names Of The Nation's Best Mesothelioma Lawyers-Better Compensation 2Health News:Mesothelioma Victims Center Urges US Navy Veterans Diagnosed With Mesothelioma To Call Them For The Names Of The Nation's Best Mesothelioma Lawyers-Better Compensation 3Health News:MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo 2Health News:MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo 3Health News:MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo 4
... The advantage that children get from living in two-parent families ... fact that their parents are married. A new study ... in stable single-parent homes generally do as well as those ... problems. "Many of the studies that show an advantage ...
... , , , ... antimicrobial skin care company, announced today that an independent testing laboratory ... H1N1 flu virus. The test results show HandClens is 99.99% ... submit these results to the FDA as an addendum to its ...
... , , NEW YORK, Aug. ... according to The Conference Board Help-Wanted OnLine Data Series (HWOL)(TM) ... with many of the largest States now showing stable trends following about ... data, there are now three States (New York, Maryland and Virginia) where ...
... , , GREENWICH, Conn., Aug. 31 ... system for treatment of bowel incontinence. Secca Therapy is ... that affects tens of millions of Americans, both young and ... of the anal canal - tightening the muscles, producing better ...
... , , , ... WTW ) announced today the start of the second annual Lose ... obesity and hunger. Between August 30th and October 17th, as Weight ... to $1 million to two hunger fighting organizations - Share Our Strength ...
... Italy, August 31 Health Robotics today announced,that ... agreed to,immediately install its flagship CytoCare Robot during ... an exclusive 3-year distribution,licensing, and support contract with ... and Pinnaclemed desire to safely, accurately, and,cost-effectively automate ...
Cached Medicine News:Health News:Family stability may be more crucial than 2 parents for child success 2Health News:Family stability may be more crucial than 2 parents for child success 3Health News:Tests Confirm HandClens(R) Hand Sanitizer Kills H1N1 Flu Virus 2Health News:Tests Confirm HandClens(R) Hand Sanitizer Kills H1N1 Flu Virus 3Health News:Online Job Demand Up 169,000 in August, The Conference Board Reports 2Health News:Online Job Demand Up 169,000 in August, The Conference Board Reports 3Health News:Online Job Demand Up 169,000 in August, The Conference Board Reports 4Health News:Online Job Demand Up 169,000 in August, The Conference Board Reports 5Health News:Online Job Demand Up 169,000 in August, The Conference Board Reports 6Health News:Online Job Demand Up 169,000 in August, The Conference Board Reports 7Health News:Secca(R) Therapy - An Effective and Minimally Invasive Option for Treating Bowel Incontinence - Launched in the US 2Health News:Weight Watchers Launches Second Annual Lose For Good(TM) Campaign 2Health News:Weight Watchers Launches Second Annual Lose For Good(TM) Campaign 3Health News:Weight Watchers Launches Second Annual Lose For Good(TM) Campaign 4Health News:Weight Watchers Launches Second Annual Lose For Good(TM) Campaign 5Health News:Health Robotics Expands CytoCare(TM) Global Presence With National Taiwan University Hospital and Pinnaclemed 2Health News:Health Robotics Expands CytoCare(TM) Global Presence With National Taiwan University Hospital and Pinnaclemed 3Health News:Health Robotics Expands CytoCare(TM) Global Presence With National Taiwan University Hospital and Pinnaclemed 4
(Date:5/17/2013)... , May 17, 2013 The power ... most important ways in which mankind depends on the ... Botanical Garden,s multifaceted exhibition Wild Medicine: ... Garden, on view from May 18 through September ... The featured exhibition,s many attractions include a ...
(Date:5/17/2013)... CHAPEL HILL, N.C. , May 17, 2013 ... on how organizations communicate internally. Faced with a ... adjust their strategies and tactics for communicating with ... the effectiveness of all the strategies, tactics and ... In a new study, Best ...
(Date:5/17/2013)... May 17, 2013 Research ... and outcomes research also   to   be presented ... SHPG ), the global specialty biopharmaceutical company, announces ... presentations at the American Psychiatric Association (APA) 166th Annual ... 18-22. The data being presented represent Shire,s ongoing commitment ...
Breaking Medicine Technology:Wild Medicine On View at The New York Botanical Garden Through Sept. 8 2Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 3Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 4Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 5Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 6Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 7Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 8Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 9Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 10
... the FDA announced,approval for the first clinical trials on ... Christian Drapeau says the experts may not be,telling the ... less,risk. , "While the FDA ... the shackles of politics," said Drapeau. "The expert commentary ...
... of MSI-1436 in DIO Rats Highlighted -PLYMOUTH MEETING, ... Corporation (Nasdaq: GENR ) today announced ... (MSI-1436), Genaera,s lead drug candidate for the treatment ... Keystone Symposia: Obesity - Novel Aspects of the ...
Cached Medicine Technology:FDA Stem Cell Approval Breakthrough Laudable 2Genaera Presents Promising Preclinical Data for Trodusquemine (MSI-1436) at Keystone Symposia 2Genaera Presents Promising Preclinical Data for Trodusquemine (MSI-1436) at Keystone Symposia 3
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 6.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 11.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 9.0 mm and length 8 mm....
Medicine Products: